Noxopharm SOF-SKN Data Shows Prolonged Skin Retention with Minimal Systemic Absorption
Summary
Noxopharm's SOF-SKN shows 3.5-day skin retention, minimal systemic absorption in preclinical tests, guiding dosing regimens and regulatory filings.
Description
Noxopharm's SOF-SKN shows 3.5-day skin retention, minimal systemic absorption in preclinical tests, guiding dosing regimens and regulatory filings.
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source